Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-057441
Filing Date
2025-12-16
Accepted
2025-12-16 17:11:04
Documents
1
Period of Report
2025-12-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1765923061.html 4  
1 FORM 4 wk-form4_1765923061.xml 4 11080
  Complete submission text file 0001628280-25-057441.txt   12797
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Issuer) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O GINKGO BIOWORKS HOLDINGS, INC. 27 DRYDOCK AVENUE, 8TH FLOOR BOSTON MA 02210
Business Address
Coen Steven P. (Reporting) CIK: 0001977441 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40097 | Film No.: 251576405